Announcement
03 Feb 2022
In February 2022, BARDA announced collaborating with Detect Inc. for the advancement of a COVID-19 rapid molecular diagnostic test.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
03 Feb 2022
Revocation date:
No revocation date
On 3 February 2022, Biomedical Advanced Research and Development Authority (BARDA) announced providing USD 22.9 million to Detect, Inc. to help the company in the development of an over-the-counter...
See all
This state act is not part of any Thread yet.